REVENUE (Tables)

9 Months Ended

Sep. 30, 2019

Revenue from Contract with Customer [Abstract]

Schedule of the Impact of Adoption of Standards

Adoption of the standard impacted the Company’s results as follows (in thousands):

	Prior to ASC 606 Adoption			Adjustments for ASC 606			Subsequent to ASC 606 Adoption
	As of September 30, 2019
Condensed Consolidated Balance Sheets
Accounts receivable, net	$	336,303		$	—		$	336,303
	Nine Months Ended September 30, 2019
Condensed Consolidated Statement of Comprehensive Income (Loss)
Net revenue	$	1,644,903		$	(55,265	)	$	1,589,638
Provision for doubtful accounts	(55,265		)	55,265			—
Operating loss	(14,600		)	—			(14,600		)
Condensed Consolidated Statements of Cash Flows
Changes in operating cash flows:
Accounts receivable, net	71,029			—			71,029
	As of December 31, 2018
Condensed Consolidated Balance Sheets
Accounts receivable, net	$	310,169		$	—		$	310,169
	Nine Months Ended September 30, 2018
Condensed Consolidated Statement of Comprehensive Income (Loss)
Net revenue	$	1,479,058		$	(44,997	)	$	1,434,061
Provision for doubtful accounts	(44,997		)	44,997			—
Operating Income	24,721			—			24,721
Condensed Consolidated Statements of Cash Flows
Changes in operating cash flows:
Accounts receivable, net	(32,483		)	—			(32,483		)

Schedule of Net Revenue Earned by Category of Payer

The following table sets forth the net revenue earned by category of payer for the three and nine months endedSeptember 30, 2019 and 2018 (in thousands):

	Three Months Ended   September 30,				Nine Months Ended   September 30,
	2019		2018		2019		2018
Commercial payers	$	525,927	$	428,873	$	1,373,481	$	1,256,109
Government payers	80,280		56,511		194,875		160,939
Patients	9,673		8,544		21,282		17,013
Net revenue	$	615,880	$	493,928	$	1,589,638	$	1,434,061